Global Live Cell Encapsulation Market expected to grow to USD 318.06 million by 2033
From GlobeNewswire: 2024-07-03 22:00:00
The Global Live Cell Encapsulation Market is expected to grow from USD 225.10 Million in 2023 to USD 318.06 Million by 2033 with a CAGR of 3.52%. Live cell encapsulation technology uses a semipermeable membrane to protect cells and tissues, delivering therapies securely. Controlled release of cells and bioactive compounds, along with innovative products, will drive market growth. Natural polymers are preferred for encapsulation due to their biocompatibility and renewability. Nanoencapsulation, focusing on drug delivery, is expected to grow rapidly, offering benefits like improved drug solubility and targeting. The drug delivery segment is estimated to hold the highest revenue share in the live cell encapsulation market due to its effectiveness in treating progressive disorders. North America is expected to dominate the market, driven by drug discovery research and public-private investments. Asia Pacific is projected to grow the fastest due to support for the pharmaceutical sector and ongoing research into diseases. Major vendors in the market include AUSTRIANOVA, Merck KGaA, and Sphere Fluidics Limited. In March 2023, SG Austria (Austrianova) received an investment from Checkmate Capital Group to aid in expansion. The key target audience for the market includes market players, investors, and government authorities. The Global Live Cell Encapsulation Market is segmented based on polymer type, method, application, and region, providing a comprehensive overview for market analysis and growth opportunities.
Read more at GlobeNewswire: Global Live Cell Encapsulation Market Size To Worth USD